JOSÉ TOMÁS
RAMOS AMADOR
Catedrático de universidad
María Isabel de
José Gómez
Publicaciones en las que colabora con María Isabel de José Gómez (47)
2017
-
Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence
Pediatric Infectious Disease Journal
2015
-
Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy
Pediatric Infectious Disease Journal, Vol. 34, Núm. 5, pp. e125-e131
-
Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults
BMC Infectious Diseases, Vol. 15, Núm. 1
2014
-
Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009
BMC Infectious Diseases, Vol. 14, Núm. 1
-
Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities
Atherosclerosis, Vol. 233, Núm. 2, pp. 410-414
-
Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012
PLoS ONE, Vol. 9, Núm. 5
-
Subclinical atherosclerosis and markers of immune activation in hiv-infected children and adolescents: The carovih study
Journal of Acquired Immune Deficiency Syndromes, Vol. 65, Núm. 1, pp. 42-49
2013
-
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults
AIDS, Vol. 27, Núm. 9, pp. 1513-1516
2012
-
High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain
PLoS ONE, Vol. 7, Núm. 12
-
High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission
Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1048-1052
-
Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007
Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1053-1058
-
Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents
Pediatric Infectious Disease Journal, Vol. 31, Núm. 3, pp. 273-277
-
Trends in Drug Resistance Prevalence in HIV-1-infected Children in Madrid: 1993 to 2010 Analysis
Pediatric Infectious Disease Journal, Vol. 31, Núm. 11, pp. e213-e221
2011
-
Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 10, pp. 2362-2371
-
Erratum: HIV-infected adolescents: Relationship between atazanavir plasma levels and bilirubin concentrations (Journal of Adolescent Health (2011) 48, (100-102) DOI: 10.1016/j.jadohealth.2010.05.009)
Journal of Adolescent Health
2010
-
Análisis ecológico y perfil materno de la transmisión vertical del virus de la inmunodeficiencia humana en la Comunidad de Madrid desde 1980 hasta 2008
Acta Pediatrica Espanola, Vol. 68, Núm. 6, pp. 292-300
-
Análisis socioeconómico y demográfico de la prevalencia en niños infectados por el virus de la inmunodeficiencia humana por transmisión vertical en la Comunidad de Madrid
Acta Pediatrica Espanola, Vol. 68, Núm. 5, pp. 235-240
-
Comparison of levels of antiretroviral drugs with efficacy in children with HIV infection
Indian Journal of Pediatrics, Vol. 77, Núm. 4, pp. 397-402
-
Exposición a antirretrovirales y toxicidad mitocondrial en una cohorte de niños no infectados hijos de madres VIH positivas
Anales de Pediatria, Vol. 73, Núm. 4, pp. 180-188
-
Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients
Pediatric Infectious Disease Journal, Vol. 29, Núm. 6, pp. 563-566